van der Kolk D - Search Results

1

Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells.

van Gosliga D, Schepers H, Rizo A, van der Kolk D, Vellenga E, Schuringa JJ. van Gosliga D, et al. Among authors: van der kolk d. Exp Hematol. 2007 Oct;35(10):1538-49. doi: 10.1016/j.exphem.2007.07.001. Exp Hematol. 2007. PMID: 17889721 Free article.

2

Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells.

Peeters SD, van der Kolk DM, de Haan G, Bystrykh L, Kuipers F, de Vries EG, Vellenga E. Peeters SD, et al. Among authors: van der kolk dm. Exp Hematol. 2006 May;34(5):622-30. doi: 10.1016/j.exphem.2006.01.020. Exp Hematol. 2006. PMID: 16647568 Free article.

3

Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

van der Kolk DM, Vellenga E, Scheffer GL, Müller M, Bates SE, Scheper RJ, de Vries EG. van der Kolk DM, et al. Blood. 2002 May 15;99(10):3763-70. doi: 10.1182/blood.v99.10.3763. Blood. 2002. PMID: 11986234 Free article.

4

The role of drug efflux pumps in acute myeloid leukemia.

van der Kolk DM, de Vries EG, Müller M, Vellenga E. van der Kolk DM, et al. Leuk Lymphoma. 2002 Apr;43(4):685-701. doi: 10.1080/10428190290016773. Leuk Lymphoma. 2002. PMID: 12153153 Review.

5

Breast cancer resistance protein (BCRP) in acute leukemia.

Plasschaert SL, Van Der Kolk DM, De Bont ES, Vellenga E, Kamps WA, De Vries EG. Plasschaert SL, et al. Among authors: van der kolk dm. Leuk Lymphoma. 2004 Apr;45(4):649-54. doi: 10.1080/10428190310001597928. Leuk Lymphoma. 2004. PMID: 15160935 Review.

6

Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells.

van der Kolk DM, de Vries EG, Koning JA, van den Berg E, Müller M, Vellenga E. van der Kolk DM, et al. Among authors: van den berg e. Clin Cancer Res. 1998 Jul;4(7):1727-36. Clin Cancer Res. 1998. PMID: 9676848

7

Multidrug resistance protein MRP1, glutathione, and related enzymes. Their importance in acute myeloid leukemia.

van der Kolk DM, Vellenga E, Müller M, de Vries EG. van der Kolk DM, et al. Adv Exp Med Biol. 1999;457:187-98. doi: 10.1007/978-1-4615-4811-9_20. Adv Exp Med Biol. 1999. PMID: 10500793 Review.

8

The role of breast cancer resistance protein in acute lymphoblastic leukemia.

Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG. Plasschaert SL, et al. Clin Cancer Res. 2003 Nov 1;9(14):5171-7. Clin Cancer Res. 2003. PMID: 14613996

9

Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity.

van Der Kolk DM, Vellenga E, van Der Veen AY, Noordhoek L, Timmer-Bosscha H, Ossenkoppele GJ, Raymakers RA, Müller M, van Den Berg E, de Vries EG. van Der Kolk DM, et al. Among authors: van der veen ay, van den berg e. Blood. 2000 Jun 1;95(11):3514-9. Blood. 2000. PMID: 10828037 Free article.

10

P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.

van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE, Vellenga E. van der Kolk DM, et al. Among authors: van putten wj. Clin Cancer Res. 2000 Aug;6(8):3205-14. Clin Cancer Res. 2000. PMID: 10955805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters